I’ve been diving into the nuances of the drug development process lately, particularly the concept of the 3Ps: Pharmacology, Pharmacokinetics, and Pharmacodynamics. It’s fascinating how understanding these can impact the design of clinical trials. Have any of you found ways to effectively communicate these concepts to stakeholders unfamiliar with biotech? Would love to hear your strategies.